Geoffrey Martha - Aug 25, 2021 Form 4 Insider Report for Medtronic plc (MDT)

Role
CEO, Director
Signature
/s/ Thomas L. Osteraas, attorney-in-fact
Stock symbol
MDT
Transactions as of
Aug 25, 2021
Transactions value $
-$820,646
Form type
4
Date filed
8/26/2021, 07:26 PM
Previous filing
Aug 4, 2021
Next filing
Aug 2, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MDT Ordinary Shares Options Exercise $81.9K +1.48K +1.55% $55.32 97.3K Aug 25, 2021 Direct F1
transaction MDT Ordinary Shares Sale -$196K -1.48K -1.52% $132.67 95.8K Aug 25, 2021 Direct F1
transaction MDT Ordinary Shares Options Exercise $634K +10.1K +10.54% $62.76 106K Aug 25, 2021 Direct F1
transaction MDT Ordinary Shares Sale -$1.34M -10.1K -9.53% $132.67 95.8K Aug 25, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -1.48K -100% $0.00* 0 Aug 25, 2021 Ordinary Shares 1.48K $55.32 Direct F1, F2, F3
transaction MDT Stock Option (Right to Buy) Options Exercise $0 -10.1K -36.57% $0.00 17.5K Aug 25, 2021 Ordinary Shares 10.1K $62.76 Direct F1, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 This option to purchase 1,808 Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Covidien acquisition, represents the conversion of an option to purchase 1,808 Medtronic Inc. common stock shares for $55.32 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option.
F3 This option to purchase 20,481 Medtronic ordinary shares for $55.32 per share, which was partially vested at the effective time of the Covidien acquisition, represents the conversion of an option to purchase 20,481 Medtronic Inc. common stock shares for $55.32 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option.
F4 This option to purchase 1,594 Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Covidien acquisition, represents the conversion of an option to purchase 1,594 Medtronic Inc. common stock shares for $62.76 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option.
F5 This option to purchase 27,619 Medtronic ordinary shares for $62.76 per share, which was unvested at the effective time of the Covidien acquisition, represents the conversion of 27,619 Medtronic common stock shares for $62.76 per share. This Medtronic plc stock option has the same terms and conditions as the original Medtronic Inc. stock option.